TNDM Q4 2022 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$221M+5.0% YoY

Gross Profit

$116M52.4% margin

Operating Income

-$18M-8.1% margin

Net Income

-$16M-7.2% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$193,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$613M

Stockholders' Equity

$440M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$221M	$210M	+5.0%
Gross Profit	$116M	$114M	+1.6%
Operating Income	-$18M	$13M	-239.6%
Net Income	-$16M	$11M	-246.7%

Geographic Segments

UNITED STATES

$166M75%

Non-US

$55M25%